Akoya Biosciences Inc (AKYA) PT Lowered to $17 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AKYA Hot Sheet
Price: $1.29 --0%
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on Akoya Biosciences Inc (NASDAQ: AKYA) to $17.00 (from $18.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
